Repositioning FDA-Approved Drugs in Combination with...

Molecular Cancer Therapeutics 2017 / 02 Vol. 16; Iss. 2

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome

Raynal, Noël J.-M., Da Costa, Elodie M., Lee, Justin T., Gharibyan, Vazganush, Ahmed, Saira, Zhang, Hanghang, Sato, Takahiro, Malouf, Gabriel G., Issa, Jean-Pierre J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0588
Date:
February, 2017
File:
PDF, 1.24 MB
english, 2017
Conversion to is in progress
Conversion to is failed